Cargando…
NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy
SIMPLE SUMMARY: Resistance to chemoradiotherapy represents a fundamental problem in modern oncology because it exposes patients to the potential negative side-effects of both radiation and chemotherapy without any clinical benefit. This study uncovers that the inflammatory signaling hub STAT3 conspi...
Autores principales: | Koerdel, Kristin, Spitzner, Melanie, Meyer, Thomas, Engels, Niklas, Krause, Florian, Gaedcke, Jochen, Conradi, Lena-Christin, Haubrock, Martin, Beißbarth, Tim, Leha, Andreas, Johnsen, Steven A., Ghadimi, B. Michael, Rose-John, Stefan, Grade, Marian, Wienands, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865718/ https://www.ncbi.nlm.nih.gov/pubmed/33530306 http://dx.doi.org/10.3390/cancers13030455 |
Ejemplares similares
-
STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
por: Spitzner, Melanie, et al.
Publicado: (2014) -
Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy
por: Flebbe, Hannah, et al.
Publicado: (2022) -
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
por: Conradi, Lena-Christin, et al.
Publicado: (2019) -
Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy
por: Jo, Peter, et al.
Publicado: (2017) -
Inhibition of Wnt/β-Catenin Signaling Sensitizes Esophageal Cancer Cells to Chemoradiotherapy
por: Spitzner, Melanie, et al.
Publicado: (2021)